NTHINasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$99.121 M
$3.33 +2.15%
Close of 21 Sept 2026
Revenue
$40.0K
#3612 by revenue
Earnings
-$62.1M
Loss-making
Shares outstanding
25,936,365
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 499 →What if Neonc Technologies were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Neonc Technologies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.
Insiders buying
All insider buying →6 open-market purchases by officers and directors of Neonc Technologies, worth $647.0K. Grants and option exercises are excluded.
37,000 shares at $3.67 on 11 Sept 2026 · filed 14 Sept 2026
47,207 shares at $4.09 on 10 Apr 2026 · filed 20 Aug 2026
12,757 shares at $5.49 on 18 Aug 2026 · filed 20 Aug 2026
36,259 shares at $3.86 on 14 Aug 2026 · filed 18 Aug 2026
9,000 shares at $5.54 on 18 Aug 2026 · filed 18 Aug 2026
15,000 shares at $3.91 on 14 Aug 2026 · filed 17 Aug 2026